Our results suggested that CTBP1-AS2 can not only be used as a prognostic and diagnostic indicator of CRC, but can also promote CRC development by regulating the miR-93-5p/TGF-β/SMAD2/3 axis (Figure 7I). This evidence concerns the gene SMAD2 and colorectal carcinoma.